ArticleJAMA neurology2020

Efficacy and Safety of 2 Fingolimod Doses vs Glatiramer Acetate for the Treatment of Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial.

Bruce A C Cree et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.